Chong Kun Dang Pharmaceutical Corp.'s latest marketcap:
As of 06/18/2025, Chong Kun Dang Pharmaceutical Corp.'s market capitalization has reached $802.11 M. According to our data, Chong Kun Dang Pharmaceutical Corp. is the 10697th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 802.11 M |
Revenue (ttm) | 1.18 B |
Net Income (ttm) | 68.89 M |
Shares Out | 13.18 M |
EPS (ttm) | 5.21 |
Forward PE | 12.85 |
Ex-Dividend Date | 12/27/2024 |
Earnings Date | 07/25/2025 |
Chong Kun Dang Pharmaceutical Corp.'s yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
06/18/2025 | ₩802.11 M | -7.69% | 10697 |
12/30/2024 | ₩1.18 T | -29.22% | 10082 |
12/28/2023 | ₩1.67 T | 66.27% | 7414 |
12/29/2022 | ₩1 T | -23.66% | 9530 |
12/30/2021 | ₩1.31 T | -49% | 8836 |
12/30/2020 | ₩2.57 T | 145.08% | 4822 |
12/30/2019 | ₩1.05 T | -0.19% | 7254 |
12/28/2018 | ₩1.05 T | -19.29% | 6390 |
12/28/2017 | ₩1.3 T | 32.54% | 6322 |
12/29/2016 | ₩983.25 B | 8.74% | 7437 |
Company Profile
About Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. is a leading pharmaceutical company specializing in the manufacturing, marketing, and sales of medicines. Headquartered in Seoul, South Korea, the company has been serving both domestic and international markets since its founding in 1941.
Product Portfolio
- Prescription Drugs: Includes anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant medications.
- Over-the-Counter (OTC) Drugs: Offers therapeutic supplements, preventive healthcare products, and general wellness solutions.
- Health Supplements: Features prebiotics, Omega-3 vitamins, and other preventive health products.
- Consumer Health Products: Includes red-ginseng healthy drinks, hand sanitizers, hair color medications, and insecticides.
Global Reach
The company actively exports its pharmaceutical and healthcare products, expanding its presence in international markets.
Frequently Asked Questions
-
What is Chong Kun Dang Pharmaceutical Corp.'s (KRX-185750) current market cap?As of 06/18/2025, Chong Kun Dang Pharmaceutical Corp. (including the parent company, if applicable) has an estimated market capitalization of $802.11 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Chong Kun Dang Pharmaceutical Corp. (KRX-185750) rank globally by market cap?Chong Kun Dang Pharmaceutical Corp. global market capitalization ranking is approximately 10697 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.